Form 4 Filing for Jon Faiz Kayyem

Jon Faiz Kayyem, a director at Inhibrx Biosciences, Inc. (INBX), reported a transaction on September 16, 2026. He acquired 5,000 shares of common stock at a price of $100 per share. Following this transaction, Kayyem